In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease
© 2017 The Author(s). Calcific aortic valve disease (CAVD) is the most prevalent valvular heart disease in the Western population, claiming 17000 deaths per year in the United States and affecting 25% of people older than 65 years of age. Contrary to traditional belief, CAVD is not a passive, degene...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Portland Press Ltd.,
2021-10-27T20:29:08Z.
|
| Subjects: | |
| Online Access: | Get fulltext |